Evidence map›Paper›PMID 39939528›Full record

ArticleCell biochemistry and biophysics2025

Integration of In Vitro and In-Silico Analysis of Gracilaria edulis on Anti-Cancer Potential and Apoptotic Signaling Pathway Activity.

Thilina Lakmini Gunathilaka, Hiruni S Kumarasinghe, U E Bandaranayake, Maheshi Athapaththu, Kalpa W Samarakoon, Pathmasiri Ranasinghe, L Dinithi C Peiris

Abstract read
PubMed Publisher
In one paragraph

Article in Cell biochemistry and biophysics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Thilina Lakmini GunathilakaDepartment of Zoology, Faculty of Applied Sciences, University of Sri Jayewardenepura, Nugegoda, 10250, Sri Lanka. thilina@dss.cmb.ac.lk.
Hiruni S KumarasingheDepartment of Interdisciplinary Graduate Program in Advanced Convergence Technology and Science, Jeju National University, Jeju-si, South Korea.
U E BandaranayakeECU Sri Lanka campus, Sri Jayewardenepura Mawatha, Rajagiriya, Sri Lanka.
Maheshi AthapaththuIndustrial Technology Institute, Colombo, Sri Lanka.
Kalpa W SamarakoonInstitute for Combinatorial Advanced Research and Education (KDU-CARE), General Sir John Kotelawala Defence University, Ratmalana, 10390, Sri Lanka.
Pathmasiri RanasingheIndustrial Technology Institute, Colombo, Sri Lanka.
L Dinithi C PeirisDepartment of Zoology/Genetics & Molecular Biology Unit, Faculty of Applied Sciences, University of Sri Jayewardenepura, Nugegoda, 10250, Sri Lanka. dinithi@sci.sjp.ac.lk.

Funding

University of Sri Jayewardenepura ASP/01/RE/SCI/2017/50
6 · The paper itself

Abstract

Breast cancer, the most common malignancy in females, and rhabdomyosarcoma (RMS), the most prevalent soft tissue sarcoma in children, remain significant clinical challenges. This study evaluated the anticancer potential and apoptotic signaling pathways of Gracilaria edulis extracts and identified their mechanisms of action against RMS and breast adenocarcinoma (MCF-7) cell lines. Cytotoxicity was assessed using MTT assays, while apoptotic potential was evaluated through phase contrast and fluorescence microscopy, caspase 3/7 activity, DNA fragmentation, and gene expression analysis of apoptosis regulatory genes. In silico analysis was also performed to examine the molecular interactions of bioactive compounds present in Gracilaria edulis with cancer-related proteins involved in apoptotic signaling. The methanol extract was fractionated into hexane, chloroform, and ethyl acetate, with the hexane fraction demonstrating the strongest cytotoxicity (IC

Indexed as

Antineoplastic AgentsAntineoplastic Agents, PhytogenicApoptosisPlant ExtractsSignal Transductionbcl-2-Associated X ProteinCaspase 3Caspase 7Computer SimulationCyclin-Dependent Kinase Inhibitor p21DNA FragmentationEdible SeaweedsGracilariaHumansMCF-7 CellsMolecular Docking SimulationAntineoplastic AgentsAntineoplastic Agents, Phytogenicbcl-2-Associated X ProteinCaspase 3Caspase 7Cyclin-Dependent Kinase Inhibitor p21Plant ExtractsProto-Oncogene Proteins c-bcl-2Tumor Suppressor Protein p53Anti-cancer activityIn-silico studiesIn-vitro studiesMCF-7RMS

Identifiers

PMID39939528

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.